SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Библиографические подробности
Главный автор:	Meem, Manila
Другие авторы:	Akter, Dr. Raushanara
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2023
Предметы:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
Online-ссылка:	http://hdl.handle.net/10361/18081

Схожие документы

A review on potential of PARP inhibitors in the treatment of prostate cancer
по: Islam, Saidul
Опубликовано: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
по: Ratu, Tabassum
Опубликовано: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
по: Emon, Kamrul Hasan
Опубликовано: (2022)

Identification of FAP inhibitors using in silico simulation study
по: Deeba, Maliha Tasnim
Опубликовано: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
по: Oshin, Sadia Afrin
Опубликовано: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
по: Karim, Azrin
Опубликовано: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
по: Mirza, Maisa Tasnim
Опубликовано: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
по: Khan, Muidul Hasan
Опубликовано: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
по: Haque, Mushfiqul
Опубликовано: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
по: Islam, Nahidul
Опубликовано: (2023)

A review on targeted therapies for lung cancer
по: Ashraf, Anushey
Опубликовано: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
по: Afroza, Halima
Опубликовано: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
по: Sorno, Rubina Haque
Опубликовано: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
по: Mahin, Md. Tamjidur Rahman
Опубликовано: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
по: Alam, Kazi Tasnuva
Опубликовано: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
по: Fred, Namanda Rogers
Опубликовано: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
по: Khandker, Tahia Anjum
Опубликовано: (2024)

Synthesis and sar o acne medication
по: Naureen, Tasnia
Опубликовано: (2024)

HPLC method development for the analysis of linagliptin
по: Mimiya, Ruhani Amrin
Опубликовано: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
по: Paul, Pulock
Опубликовано: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
по: Kamal, Tasnova
Опубликовано: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
по: Tania, Umme
Опубликовано: (2023)

Trend in approval of targeted biologics in the last two decades
по: Siddika, Khadiza
Опубликовано: (2024)

Breast cancer therapy through Liposomal drug delivery system
по: Ome, Nusrat Jahan
Опубликовано: (2024)

Epigenetic therapy in cancer
по: Abid, Md. Shadman Ridwan
Опубликовано: (2021)

A review on triple-negative breast cancer and its potential treatment
по: Niasa, Jannatul Ferdous
Опубликовано: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
по: Razna, Amrin Islam
Опубликовано: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
по: Chakraborty, Anuradha
Опубликовано: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
по: Nahar, Kamrun
Опубликовано: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
по: Nashrah, Zannatul
Опубликовано: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
по: Hoque, Syeda Mehren
Опубликовано: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
по: Parvez, Safi
Опубликовано: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
по: Sarkar, Onusree
Опубликовано: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
по: Hasan, Amit
Опубликовано: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
по: Dowla, Rumana, и др.
Опубликовано: (2022)